Have a personal or library account? Click to login
Dose-related effects of clozapine and risperidone on the pattern of brain regional serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats Cover

Dose-related effects of clozapine and risperidone on the pattern of brain regional serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats

Acta Pharmaceutica
Volume 60 (2010): Issue 2 (June 2010)
By: Farhat Batool,  Ambreen Hasnat,  Muhammad Haleem and  Darakhshan Haleem  
Open Access
|Dec 2010

References

  1. S. Miyamoto, G. E. Duncan, C. E. Marx and J. A. Lieberman, Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs, Mol. Psychiatry 10 (2005) 79-104; DOI: 10.1038/sj.mp.4001556.10.1038/sj.mp.4001556
    Search in Google Scholar
  2. S. Natesan, G. E. Reckless, K. B. Barlow, J. N. Nobrega and S. Kapur, Amisulpride the ‘atypical’ atypical antipsychotic-comparison to haloperidol, risperidone and clozapine, Schizophr. Res. 105 (2008) 224-235; DOI: 10.1016/j.schres.2008.07.005.10.1016/j.schres.2008.07.005
    Search in Google Scholar
  3. V. Bigliani, R. S. Mulligan, P. D. Acton, D. Visvikis, P. J. Ellm, C. Stephenson, R. W. Kerwin and L. S. Pilowsky, In vivo occupancy of striatal and temporal cortical D2/D3 dopamine receptors by typical antipsychotic drugs. [123I] epidepride single photon emission tomography (SPET) study, Brit. J. Psychiat. 175 (1999) 231-238; DOI: 10.1192/bjp.175.3.231.10.1192/bjp.175.3.231
    Search in Google Scholar
  4. S. Leucht, C. Corves, D. Arbter, R. R. Engel, C. Li and J. M. Davis, Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis, Lancet 373 (2009) 31-41; DOI: 10.1016/S0140-6736(08)61764-X.10.1016/S0140-6736(08)61764-X
    Search in Google Scholar
  5. M. L. Wadenberg, S. Kapur, A. Soliman, C. Jones and F. Vaccarino, Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats, Psychopharmacology 150 (2000) 422-429; DOI: 10.1007/s002130000466.10.1007/s002130000466
    Search in Google Scholar
  6. J. T. Trevitt, M. Lyons, J. Aberman, D. Carriero, M. Finn and J. D. Salamone, Effects of clozapine, thioridazine, risperidone and haloperidol on behavioral tests related to extrapyramidal motor function, Psychopharmacology 132 (1997) 74-81; DOI: 10.1007/s002130050322.10.1007/s002130050322
    Search in Google Scholar
  7. S. Kapur and P. Seeman, Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics?: A new hypothesis, Am. J. Psychiat. 158 (2000) 360-369; DOI: 10.1176/appi.ajp.158.3.360.10.1176/appi.ajp.158.3.360
    Search in Google Scholar
  8. A. Newman, C. Chaput, L. Verriele and M. J. Millan, Clozapine is a partial agonist at cloned human serotonin 5-HT1A receptors, Neuropharmacology 35 (1996) 119-121; DOI: 10.1016/0028-3908 (95)00170-0.
    Search in Google Scholar
  9. S. Szymanski, J. Lieberman, S. Pollack, R. Munne, A. Safferman, J. Kane, M. Kronig and T. Cooper, The dopamine-serotonin relationship in clozapine response, Psychopharmacology 112 (1993) S85-S89; DOI: 10.1007/BF02245011.10.1007/BF02245011
    Search in Google Scholar
  10. M. Campbell, P. I. Young, D. N. Bateman, J. M. Smith and S. H. Thomas, The use of atypical antipsychotics in the management of schizophrenia, Br. J. Clin. Pharmaco. 47 (1999) 13-22; DOI: 10.1046/j.1365-2125.1999.00849.x.10.1046/j.1365-2125.1999.00849.x
    Search in Google Scholar
  11. R. Kumar, G. Palit and B. N. Dhawan, Comparative behavioral effects of typical and atypical antipsychotic drugs in rhesus monkey, Eur. J. Pharmacol. 462 (2003) 133-138; DOI: 10.1016/S0014-2999(02)02957-6.10.1016/S0014-2999(02)02957-6
    Search in Google Scholar
  12. R. A. Bressan, K. Erlandsson, H. M. Jones, R. S. Mulligan, P. J. Ell and L. S. Pilowsky, Optimizing limbic selective D2/D3 receptor occupancy by risperidone: a [123I]-epidepride SPET study, J. Clin. Psychopharm. 23 (2003) 5-14; DOI: 10.1097/00004714-200302000-00002.10.1097/00004714-200302000-00002
    Search in Google Scholar
  13. D. J. Haleem, F. Batool, N. H. Khan, N. Kamil, O. Ali, Z. S. Saify and M. A. Haleem, Differences in the effects of haloperidol and clozapine on brain serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats, Med. Sci. Monit. 8 (2002) 354-361.
    Search in Google Scholar
  14. F. Batool, S. Ahmed and D. J. Haleem, Dietary supplementations of amino acids: evidence for enhanced serotonergic functions following haloperidol withdrawal in rat medial prefrontal cortex, J. Coll. Physicians Surg. Pak. 9 (2009) 139-145.
    Search in Google Scholar
  15. D. J. Haleem, Z. S. Saify, S. Siddiqui, F. Batool and M. A. Haleem, Pre- and postsynaptic responses to 1-(1-naphthylpiperazine) following adaptation to stress in rats, Prog. Neuro-Psychoph. 26 (2002) 149-56; DOI: 10.1016/S0278-5846(01)00240-8.10.1016/S0278-5846(01)00240-8
    Search in Google Scholar
  16. L. S. Pilowsky, D. C. Costa, P. J. Ell, N. P. Verhoeff, R. M. Murray and R. W. Kerwin, D2 dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerized tomography study, Brit. J. Psychiat. 164 (1994) 16-26; DOI: 10.1192/bjp.164.1.16.10.1192/bjp.164.1.16
    Search in Google Scholar
  17. Q. C. Meng, Y. F. Chen and S. Oparil, A simple method for concentration of biogenic amines and their metabolites from biological samples for analysis by HPLC-EC, Life Sci. 44 (1989) 1207-1213; DOI: 10.1016/0024-3205(89)90316-0.10.1016/0024-3205(89)90316-0
    Search in Google Scholar
  18. N. Samad, F. Batool and D. J. Haleem, Neurochemical and behavioral effects of 8-OH-DPAT following exposure to restraint stress in rats, Pharmacol. Rep. 59 (2007) 173-180.
    Search in Google Scholar
  19. J. de Jong, U. R. Tjaden, E. Visser and W. H. Meijer, Determination of serotonin and 5-hydroxy-indoleacetic acid in urine by reversed-phase ion-pair partition chromatography with fluorimetric detection, J. Chromatogr. 7 (1987) 85-94.10.1016/0378-4347(87)80268-2
    Search in Google Scholar
  20. L. Farde, A. L. Nordstrom, F. A. Wiesel, S. Pauli, C. Halldin and G. Sedvall, Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects, Arch. Gen. Psychiat. 49 (1992) 538-544; DOI: 10.1016/0024-3205(78)90035-8.10.1016/0024-3205(78)90035-8
    Search in Google Scholar
  21. T. J. Crow, E. C. Johnstone, A. J. Longden and F. Owen, Dopaminergic mechanisms in schizophrenia: the antipsychotic effect and the disease process, Life Sci. 23 (1978) 563-567; DOI: 10.1016/0024-3205(78)90035-8.10.1016/0024-3205(78)90035-8
    Search in Google Scholar
  22. D. Pickar, T. P. Su, D. R. Weinberger, R. Coppola, A. K. Malhotra, M. B. Knable, K. S. Lee, J. Gorey, J. J. Bartko, A. Breier and J. Hsiao, Individual variation in D2 dopamine receptor occupancy in clozapine-treated patients, Am. J. Psychiat. 153 (1996) 1571-1578.10.1176/ajp.153.12.1571
    Search in Google Scholar
  23. H. Y. Meltzer and M. Huang, In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems, Prog. Brain Res. 172 (2008) 177-197; DOI: 10.1016/S0079-6123(08)00909-6.10.1016/S0079-6123(08)00909-6
    Search in Google Scholar
  24. X. Xiberas, J. L. Martinot, L. Mallet, E. Artiges, C. Loc'H, B. Mazière and M. L. Paillère-Martinot, Extrastriatal and striatal D2 dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia, Brit. J. Psychiat. 179 (2001) 503-508; DOI: 10.1192/bjp.179.6.503.10.1192/bjp.179.6.50311731352
    Search in Google Scholar
  25. S. Nyberg, L. Farde, L. Eriksson, C. Halldin and B. Eriksson, 5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone, Psychopharmacology 110 (1993) 265-272; DOI: 10.1007/BF02251280.10.1007/BF022512807530376
    Search in Google Scholar
DOI: https://doi.org/10.2478/v1007-010-0014-y | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 129 - 140
Published on: Dec 6, 2010
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
atypical antipsychotics,
dopamine D receptors,
extrapyramidal side effects,
serotonin receptors,
schizophrenia
Related subjects:
Pharmacy,
Pharmacy, other

© 2010 Farhat Batool, Ambreen Hasnat, Muhammad Haleem, Darakhshan Haleem, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.

Volume 60 (2010): Issue 2 (June 2010)